- Article
Background: Autophagy is implicated in cancer progression and therapeutic response, but the effects of the DNA-demethylating agent decitabine (5-aza-dC) on autophagy-related pathways in non-small-cell lung cancer (NSCLC) remain incompletely defined. Objective: This study investigated treatment-associated changes in BECN1, SQSTM1, and MTOR using integrated bioinformatic and experimental approaches. Method: GEPIA2 and STRING were used to assess gene expression, clinical associations, correlations, and functional interactions in LUAD and LUSC. A549 and NCI-H460 cells were treated with 2.5 or 5 µM 5-aza-dC for 72 h, followed by RT-qPCR, Western blotting, and acridine-orange flow cytometry. Results: Bioinformatic analysis revealed subtype-dependent expression patterns and positive correlations of BECN1 with MTOR and SQSTM1, although none of the three genes was significantly associated with overall survival. Experimentally, 5-aza-dC reduced MTOR mRNA in both cell lines, whereas BECN1 and SQSTM1 showed cell-dependent responses. Protein analysis demonstrated increased Beclin-1 and SQSTM1/p62 abundance, while total mTOR was significantly reduced only in H460 cells at 5 µM. Acridine-orange fluorescence increased after treatment, particularly in H460 cells at 5 µM. Conclusions: 5-aza-dC induces cell-line-dependent changes in autophagy-related transcripts and proteins in NSCLC cells. However, these findings do not establish mTORC1 activity, autophagic flux, or direct promoter demethylation.
11 November 2026





![Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) flow diagram [31]. Of 596 full-text reports assessed, 338 records were included in the evidence map (322 empirical primary studies and 16 contextual records), 143 were retained outside the evidence map for background, comparator, or citation-tracking purposes, and 115 were excluded or non-qualifying. Individual full-text exclusion or non-qualifying reasons are reported in Supplementary Table S3. Of the 143 retained outside the map, 81 are documented in Table S2 (69 background/secondary and 12 comparator reports), and 62 are documented separately in Table S8. Ten excluded/non-human entries are intentionally listed in both Tables S2 and S3 for traceability, not counted twice. The 15 reports not retrieved were not among the 596 assessed full texts.](https://mdpi-res.com/epigenomes/epigenomes-10-00070/article_deploy/html/images/epigenomes-10-00070-g001-550.jpg)